These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21437437)

  • 21. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
    Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA
    Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era.
    Malinis MF; Chen S; Allore HG; Quagliarello VJ
    Ann Transplant; 2014 Sep; 19():478-87. PubMed ID: 25256592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation.
    Leibovici-Weissman Y; Mor E; Leshno M; Shlomai A
    Dig Dis Sci; 2017 Mar; 62(3):801-807. PubMed ID: 28054162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients.
    Guo Z; He X; Wu L; Ju W; Hu A; Tai Q; Wang D; Ma Y; Wang G; Zhu X; Huang J
    Surg Today; 2010; 40(1):38-45. PubMed ID: 20037838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort study.
    Cardoso FS; Karvellas CJ; Kneteman NM; Meeberg G; Fidalgo P; Bagshaw SM
    Can J Gastroenterol Hepatol; 2015 May; 29(4):185-91. PubMed ID: 25965438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
    Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis.
    Vitale A; Saracino E; D'Amico FE; Grigoletto F; Burra P; Angeli P; Boccagni P; Brolese A; Zanus G; Neri D; Gringeri E; D'Amico F; Valmasoni M; Carraro A; Gambato M; Feltracco P; Romano A; Buggio M; D'Amico DF; Cillo U
    Transplant Proc; 2009 May; 41(4):1092-5. PubMed ID: 19460489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver Transplantation Outcomes in Recipients with High Model for End-Stage Liver Disease (MELD) Scores: The Relevance of MELD Scores.
    Wronka KM; Grąt M; Stypułkowski J; Bik E; Krasnodębski M; Masior Ł; Grąt K; Patkowski W; Krawczyk M
    Ann Transplant; 2017 Apr; 22():251-256. PubMed ID: 28439063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D-MELD does not predict post-liver transplantation survival: a single-center experience from Brazil.
    Costabeber AM; Lionço LC; Marroni C; Zanotelli ML; Cantisani G; Brandão A
    Ann Hepatol; 2014; 13(6):781-7. PubMed ID: 25332264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LIVER RETRANSPLANTATION: PROGNOSTIC SCORES AND RESULTS IN THE STATE OF PARANÁ.
    Freitas ACT; Giacomitti IS; Almeida VM; Coelho JCU
    Arq Bras Cir Dig; 2024; 37():e1802. PubMed ID: 38775559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proposal of Muscle-MELD Score, Including Muscularity, for Prediction of Mortality After Living Donor Liver Transplantation.
    Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yagi S; Hammad A; Okajima H; Uemoto S
    Transplantation; 2016 Nov; 100(11):2416-2423. PubMed ID: 27495765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of MELD Score-Based Organ Allocation on Mortality, Bleeding, and Transfusion in Liver Transplantation: A Before-and-After Observational Cohort Study.
    Massicotte L; Carrier FM; Karakiewicz P; Hevesi Z; Thibeault L; Nozza A; Bilodeau M; Roy A; Denault AY
    J Cardiothorac Vasc Anesth; 2019 Oct; 33(10):2719-2725. PubMed ID: 31072701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Living-Donor Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Score and Predictive Value of NLR on Survival.
    Hung HC; Lee JC; Wang YC; Cheng CH; Wu TH; Wu TJ; Chou HS; Chan KM; Lee WC; Lee CF
    Curr Oncol; 2022 May; 29(6):3881-3893. PubMed ID: 35735419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics.
    Bhat M; Ghali P; Dupont B; Hilzenrat R; Tazari M; Roy A; Chaudhury P; Alvarez F; Carrier M; Bilodeau M
    J Hepatol; 2017 Feb; 66(2):374-381. PubMed ID: 27751840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.